In today’s fast-paced clinical environment, it is helpful to understand how ultrasound integrates new artificial intelligence technologies to best serve both physicians and patients. Specifically, how AI can improve patient satisfaction, increase medical professionals’ workflow efficiency, expand scientific knowledge and explore disease prediction models.
- To review the different types of machine learning (ML) techniques
- To understand how ML algorithms could be incorporated in practice to improve echo lab workflow
- Characterize the challenges and opportunities related to the application of AI in echocardiography in the COVID-19 era
- Understand the potential for AI technology in improving patient satisfaction and clinical outcomes
To review the different types of machine learning (ML) techniques To understand how ML algorithms could be incorporated in practice to improve echo lab workflow Characterize the challenges and opportunities related to the application of AI in echocardiography in the COVID-19 era Understand the potential for AI technology in improving patient satisfaction and clinical outcomes
This CME activity has been planned and implemented in accordance with the Essential Areas and Policies of the Accreditation Council for Continuing Medical Education. Northwest Imaging Forums is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians. NWIF designates this live activity for a maximum of 1.0 hour AMA PRA Category 1 Credits™. Physicians should only claim credit commensurate with the extent of their participation in the activity.
Release Date: 01/20/2025 | Expires: 01/20/2026
Faculty and Planner Disclosures:
As an accredited provider of continuing medical education, it is the policy of Northwest Imaging Forums, Inc. (NWIF) to ensure balance, independence, objectivity, and scientific rigor in all of its activities. In accordance with this policy, faculty and planners must disclose any financial relationships with ineligible companies. Additionally, in the event a relevant financial relationship does exist, it is the policy of NWIF to ensure that the relevant financial relationship is mitigated in order to ensure the integrity of the CME activity. The planner has nothing to disclose.
Jordan B. Strom, MD, MSc, FACC, FASE
- Edwards Life Sciences
- Bracco
- Ultromics and Heart Sciences
Patricia A. Pellikka, MD, FACC, FAHA, FASE
- Ultromics LTD
- American Society of Echo Foundation
Partho Sengupta, MD, DM, FACC, FASE
- Ultromics LTD
- Kencor Health
- RCE Technologies
Jordan B. Strom
MD, MSc, FACC, FASE
Harvard Medical School
Boston, MA
Patricia A. Pellikka
MD, FACC, FAHA, FASE
Mayo Clinic
Rochester, MN
Partho Sengupta
MD, DM, FACC, FASE
WVU Heart & Vascular Institute
Morgantown, WV
